ValGenesis to bring real-world AI-Assisted Validation insights to KENX Europe 2026. * 1 hr ago ValGenesis Inc., the leader in enterprise digital validation, will explore real-world insights into the practical application of AI-assisted validation at KENX Europe 2026: Harnessing the Power of AI in GxP, taking place Oct. 14-15, 2026, at the Four Elements Hotel Amsterdam in Amsterdam, the Netherlands. As life sciences organizations move from exploring AI's potential to applying it in regulated environments, questions around performance, governance, and human oversight are becoming increasingly important. ValGenesis is addressing these challenges through AI-native digital validation and VAL(TM)(ValGenesis AI), the governed AI natively built into the ValGenesis Smart GxP(TM) platform. VAL applies AI throughout the validation lifecycle while keeping humans in control of oversight, approval, and critical decisions. Its capabilities include generating validation documents, identifying potential compliance and test-coverage gaps, interpreting execution evidence, detecting anomalies, and analyzing document changes. "AI is moving beyond theory and into practical use in GxP environments," said David Medina, chief marketing officer at ValGenesis. "The challenge now is understanding where it adds meaningful value, how to evaluate the results, and how to maintain appropriate control. At KENX Europe, we'll share what we're learning from practical applications of AI in validation and the considerations organizations should address as they expand its use." Kenneth Pierce, Ph.D., director of product growth at ValGenesis, will lead two sessions focused on evaluating AI performance and building trust in its use in GxP environments. "How Would You Know It Worked? Measuring AI-Assisted Validation in Practice" will draw on customer pilot studies, implementation lessons, and measurable performance outcomes to examine how organizations can evaluate AI-assisted validation. "Pacing the Frontier: AI in GxP Life Sciences Operations" will introduce an AI maturity model for building trust in AI-supported processes and expanding adoption through clearly defined intended-use frameworks. ValGenesis is a Platinum Sponsor of KENX Europe 2026 and will host an exhibit booth and sponsor the event's cocktail reception. About ValGenesis, Inc. ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP(TM) platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com. Media gallery

ValGenesis, the digital validation lifecycle management platform provider, has appointed Wayne Baker as chief revenue officer. Baker will oversee global sales strategy, customer expansion, and commercial execution across key markets. Baker brings over 25 years of experience in technology and life sciences. He previously served as chief commercial officer at Greenphire and chief sales officer at Advanced Health Media. The appointment comes as life sciences companies increasingly adopt AI-enabled validation processes. ValGenesis offers Smart GxP, an AI-native validation platform, and VAL, a governed AI system for executing validation work. Baker will focus on scaling global sales and helping customers adopt the company's platform across validation, process development, and manufacturing. ValGenesis serves life sciences companies worldwide, digitising commissioning, qualification, and validation processes.

Ulrich Medical Selects ValGenesis iVal(TM) for SAP-Driven CSV Upgrade. SANTA CLARA, Calif.-(BUSINESS WIRE)-ValGenesis Inc., the market leader in enterprise digital validation, announced that Ulrich Medical has selected ValGenesis iVal(TM) to modernize computer system validation (CSV) processes in support of its broader digital transformation and upcoming SAP implementation. Ulrich Medical has selected ValGenesis iVal(TM) to modernize computer system validation (CSV) processes in support of its broader digital transformation and upcoming SAP implementation. Share The Germany-based medical device company will replace manual validation processes with a digital approach to manage increased CSV activity associated with the SAP rollout. The initial deployment will begin at Ulrich Medical's headquarters, with plans for global expansion. Part of the AI-enabled ValGenesis Smart GxP(TM) platform, iVal centralizes validation planning, test authoring, and execution to enable more efficient and scalable CSV processes. With offline execution, automated deviation management, integrated risk assessments, and change impact analysis, the platform helps organizations streamline validation workflows, improve traceability, and maintain regulatory compliance across global operations. "Modernizing CSV was a prerequisite for our SAP rollout," said Matthias Novotny, Head of Process and Lean Management at Ulrich Medical. "ValGenesis gives us the efficiency we need to manage a significantly higher validation workload with greater accuracy and consistency, allowing us to keep pace with evolving global regulations without overstretching our team." "As medical device companies expand digital transformation initiatives and enterprise system deployments, they face growing pressure to manage validation activities more efficiently while maintaining compliance," said Anna Beamish, vice president of global sales at ValGenesis. "By implementing iVal, Ulrich Medical is moving toward a digital validation approach that can scale with its global operations and long-term growth." About Ulrich Medical Ulrich Medical develops, manufactures, and markets innovative medical technology. Founded in 1912, the company celebrates its 114th anniversary this year. Healthcare professionals worldwide rely on its decades of expertise. With product divisions in spinal implants and contrast media injectors for CT and MRI, Ulrich Medical offers a broad portfolio of advanced solutions. The company is among the few in the industry to retain both development and production in Germany, supported by state-of-the-art manufacturing technologies. As an owner-operated business, it remains independent and continues to deliver steady, sustainable growth. For more information, visit ulrichmedical.com About ValGenesis Inc. ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP(TM) platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com Contacts. Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 [email protected]